Endoscopic Intervention Timing for Acute Necrotizing Pancreatitis

(STEP-IN Trial)

This trial examines the timing of a procedure called endoscopic drainage to treat infected necrotizing pancreatitis, a severe condition where part of the pancreas dies and becomes infected. The goal is to determine if performing the procedure earlier can prevent the condition from worsening, thereby reducing hospital stays and complications. Participants will receive the drainage treatment (EUS-guided transluminal drainage of necrotic collection) either within the first four weeks or after four weeks, once the infected area is more contained. This trial is ideal for individuals who have experienced acute pancreatitis with ongoing pain and signs of infection, as indicated by specific symptoms or tests. As an unphased trial, it offers a unique opportunity to contribute to medical knowledge and potentially improve treatment timing for future patients.

The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.

Research shows that EUS-guided drainage is generally safe and effective for treating pancreatic necrosis. Studies highlight it as a preferred treatment due to its safety. Patients undergoing this procedure often experience fewer complications and shorter hospital stays. Over time, its use has increased, enhancing its safety. Although any procedure carries risks, evidence suggests that patients generally tolerate EUS-guided drainage well.¹²³⁴⁵

Researchers are excited about this trial because it explores the timing of endoscopic intervention for acute necrotizing pancreatitis, which could significantly impact patient outcomes. Unlike traditional approaches where intervention is often delayed until the necrotic collection is fully encapsulated, this trial examines the benefits of early EUS-guided drainage within 72 hours of randomization. By comparing early versus postponed intervention, researchers hope to determine whether earlier treatment can lead to faster recovery and fewer complications, potentially setting a new standard for managing this severe condition.

Research has shown that EUS-guided drainage is becoming a preferred treatment for infected necrotizing pancreatitis. In this trial, participants will be divided into two groups to assess the timing of this intervention. The early treatment group will undergo EUS-guided drainage within 72 hours of randomization, while the postponed treatment group will have the procedure 28 days after the onset of acute pancreatitis. Studies have found this method effective and safe for treating fluid build-up around the pancreas. Acting early with this technique might prevent the patient's condition from worsening and reduce complications. Evidence also suggests it can shorten hospital stays and lower healthcare costs. Overall, EUS-guided drainage is a promising option for managing severe pancreatitis cases.²⁴⁶⁷⁸